What is LOPJLB’s current signal on ESLA?

LOPJLB’s latest quantitative signal on Estrella Immunopharma, Inc. (ESLA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ESLA in?

Estrella Immunopharma, Inc. (ESLA) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Estrella Immunopharma, Inc. (ESLA) do?

Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse l…

Where is Estrella Immunopharma, Inc. based / listed?

Estrella Immunopharma, Inc. is based in US, listed on NASDAQ.

Estrella Immunopharma, Inc. (ESLA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.41-2.38%Close

SELLCRISIS · day 28

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $18M
Beta: 0.93
P/E (TTM): -1.74

Short % float: 1.26%
Days to cover: 4.7
SI change: +39.2%

1W: -12.77%
1M: -38.81%

vs SPY 1W: -13.93%
vs SPY 1M: -41.80%

Industry peers

FMP comparable companies · ranked by market cap

IMMXSELLImmix Biopharma, Inc.$524MCRISISQ 24$9.64+1.83%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news